| Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data E Trépo, P Nahon, G Bontempi, L Valenti, E Falleti, HD Nischalke, ... Hepatology 59 (6), 2170-2177, 2014 | 250 | 2014 |
| Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells MJ Kim, V Pelloux, E Guyot, J Tordjman, LC Bui, A Chevallier, C Forest, ... Environmental health perspectives 120 (4), 508-514, 2012 | 195 | 2012 |
| The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications E Guyot, A Chevallier, R Barouki, X Coumoul Drug discovery today 18 (9-10), 479-486, 2013 | 147 | 2013 |
| PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis E Guyot, A Sutton, P Rufat, C Laguillier, A Mansouri, R Moreau, ... Journal of hepatology 58 (2), 312-318, 2013 | 125 | 2013 |
| A 17‐beta‐hydroxysteroid dehydrogenase 13 variant protects from hepatocellular carcinoma development in alcoholic liver disease J Yang, E Trépo, P Nahon, Q Cao, C Moreno, E Letouzé, S Imbeaud, ... Hepatology 70 (1), 231-240, 2019 | 98 | 2019 |
| PNPLA3 (rs738409 C> G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis E Trepo, E Guyot, N Ganne-Carrie, D Degre, T Gustot, D Franchimont, ... Hepatology 55 (4), 1307-1308, 2012 | 94 | 2012 |
| PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases J Yang, E Trépo, P Nahon, Q Cao, C Moreno, E Letouzé, S Imbeaud, ... International Journal of Cancer 144 (3), 533-544, 2019 | 93 | 2019 |
| Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis JC Nault, E Guyot, C Laguillier, S Chevret, N Ganne-Carrie, G N'Kontchou, ... Cancer epidemiology, biomarkers & prevention 22 (8), 1343-1352, 2013 | 86 | 2013 |
| Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum N Marinval, P Saboural, O Haddad, M Maire, K Bassand, F Geinguenaud, ... Marine drugs 14 (10), 185, 2016 | 42 | 2016 |
| Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis A Tarhuni, E Guyot, P Rufat, A Sutton, V Bourcier, V Grando, ... Journal of hepatology 61 (2), 342-350, 2014 | 37 | 2014 |
| Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis P Nahon, J Bamba-Funck, R Layese, E Trépo, J Zucman-Rossi, C Cagnot, ... Journal of hepatology 78 (3), 584-595, 2023 | 30 | 2023 |
| The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization S Rekik, E Guyot, M Bhais, Y Ajavon, V Grando, V Bourcier, G Nkontchou, ... Digestive and Liver Disease 48 (9), 1088-1092, 2016 | 24 | 2016 |
| miR‐126‐3p is essential for CXCL12‐induced angiogenesis K Bassand, L Metzinger, M Naïm, N Mouhoubi, O Haddad, V Assoun, ... Journal of cellular and molecular medicine 25 (13), 6032-6045, 2021 | 21 | 2021 |
| Identification of a new stilbene-derived inducer of paraoxonase 1 and ligand of the Aryl hydrocarbon Receptor E Guyot, X Coumoul, JF Chassé, F Khallouki, JF Savouret, M Poirot, ... Biochemical pharmacology 83 (5), 627-632, 2012 | 20 | 2012 |
| Determination of Heavy Metal Concentrations in Normal and Pathological Human Endometrial Biopsies and In Vitro Regulation of Gene Expression by Metals in … E Guyot, Y Solovyova, C Tomkiewicz, A Leblanc, S Pierre, S El Balkhi, ... PloS one 10 (11), e0142590, 2015 | 17 | 2015 |
| Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis M Allaire, S Rekik, R Layese, A Mumana, E Guyot, G Nkontchou, ... Digestive and Liver Disease 51 (1), 86-94, 2019 | 16 | 2019 |
| Activation of the aryl hydrocarbon receptor by carcinogenic aromatic amines and modulatory effects of their N-acetylated metabolites L Juricek, LC Bui, F Busi, S Pierre, E Guyot, A Lamouri, JM Dupret, ... Archives of toxicology 89, 2403-2412, 2015 | 16 | 2015 |
| RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway L Maillard, N Saito, H Hlawaty, V Friand, N Suffee, F Chmilewsky, ... Biology Open 3 (10), 995-1004, 2014 | 16 | 2014 |
| BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV-or HBV-related liver disease A Oussalah, PH Avogbe, E Guyot, C Chery, RM Guéant-Rodriguez, ... Oncotarget 8 (38), 62842, 2017 | 15 | 2017 |
| Heparanase and Syndecan-4 are involved in low molecular weight Fucoidan-induced angiogenesis O Haddad, E Guyot, N Marinval, F Chevalier, L Maillard, L Gadi, ... Marine drugs 13 (11), 6588-6608, 2015 | 9 | 2015 |
